![Charbel Helaihel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Charbel Helaihel worked as the VP-Marketing & Commercial Planning at Inhibrx, Inc. from 2023 to 2024.
He completed his undergraduate degree at Beirut Arab University.
Former positions of Charbel Helaihel
Companies | Position | End |
---|---|---|
INHIBRX, INC. | Sales & Marketing | 2024-05-29 |
Training of Charbel Helaihel
Beirut Arab University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Inhibrx, Inc.
![]() Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Charbel Helaihel